The NF-κB pathway is a key regulator of immune and inflammatory responses, and it has been shown to be increased in its activation in patients with progressive MS, suggesting an involvement of the latter in the MS pathogenesis processes [129]. Here, NFKB1 is linked to myeloid sarcoma.